Director/PDMR Shareholding

RNS Number : 7965Q
Spire Healthcare Group PLC
08 June 2018
 

8 June 2018

 

Spire Healthcare Group plc (the "Company")

 

 

Acquisition of Spire Healthcare shares by Peter Bamford

 

Peter Bamford, Deputy Chairman and Senior Independent Director of the Company, purchased 4,000 ordinary shares in the Company at a price of 248.0 pence each on 7 June 2018.

 

Following this announcement Mr Bamford holds a total of 9,000 ordinary shares which are held through an HSBC nominee account.

 

Enquiries:

Philip Davies

Deputy Company Secretary

020 7427 9092

 

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Peter Bamford

2

Reason for the notification

a)

Position/status

 

Deputy Chairman and Senior Independent Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

b)

Nature of the transaction

Purchase of 4,000 ordinary shares at 248.0 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

248.0 pence

4,000


d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2018-06-07

f)

Place of the transaction

XLON

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBGGDLSDGBGII
UK 100